These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 11994506)
1. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. Gürsel M; Verthelyi D; Gürsel I; Ishii KJ; Klinman DM J Leukoc Biol; 2002 May; 71(5):813-20. PubMed ID: 11994506 [TBL] [Abstract][Full Text] [Related]
2. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma. Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301 [TBL] [Abstract][Full Text] [Related]
3. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif. Zhang Y; Shoda LK; Brayton KA; Estes DM; Palmer GH; Brown WC J Interferon Cytokine Res; 2001 Oct; 21(10):871-81. PubMed ID: 11711000 [TBL] [Abstract][Full Text] [Related]
4. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides. Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475 [TBL] [Abstract][Full Text] [Related]
5. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. Ballas ZK; Rasmussen WL; Krieg AM J Immunol; 1996 Sep; 157(5):1840-5. PubMed ID: 8757300 [TBL] [Abstract][Full Text] [Related]
6. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses. Merlo A; Calcaterra C; Mènard S; Balsari A J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660 [TBL] [Abstract][Full Text] [Related]
7. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. Verthelyi D; Ishii KJ; Gursel M; Takeshita F; Klinman DM J Immunol; 2001 Feb; 166(4):2372-7. PubMed ID: 11160295 [TBL] [Abstract][Full Text] [Related]
8. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999 [TBL] [Abstract][Full Text] [Related]
9. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481 [TBL] [Abstract][Full Text] [Related]
10. Phosphorothioate oligodeoxyribonucleotides induce in vitro proliferation of chicken B-cells. Wattrang E Vet Immunol Immunopathol; 2009 Oct; 131(3-4):218-28. PubMed ID: 19447503 [TBL] [Abstract][Full Text] [Related]
11. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro. Wattrang E; Berg M; Magnusson M Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the hepatitis B virus replication in vitro by an oligodeoxynucleotide containing cytidine-guanosine motifs. Li N; Fan XG; Chen ZH; Zhu C; Liu HB; Huang Y Immunol Lett; 2006 Jan; 102(1):60-6. PubMed ID: 16105691 [TBL] [Abstract][Full Text] [Related]
14. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Vollmer J; Weeratna R; Payette P; Jurk M; Schetter C; Laucht M; Wader T; Tluk S; Liu M; Davis HL; Krieg AM Eur J Immunol; 2004 Jan; 34(1):251-62. PubMed ID: 14971051 [TBL] [Abstract][Full Text] [Related]
15. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients. Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766 [TBL] [Abstract][Full Text] [Related]
16. Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides. Zelenay S; Elías F; Fló J Eur J Immunol; 2003 May; 33(5):1382-92. PubMed ID: 12731065 [TBL] [Abstract][Full Text] [Related]
18. CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells. Gursel M; Verthelyi D; Klinman DM Eur J Immunol; 2002 Sep; 32(9):2617-22. PubMed ID: 12207346 [TBL] [Abstract][Full Text] [Related]
19. Anti-HBV effects of CpG oligodeoxynucleotide-activated peripheral blood mononuclear cells from patients with chronic hepatitis B. Li N; Fan XG; Chen ZH; Huang Y; Quan J; Liu ZB APMIS; 2005 Oct; 113(10):647-54. PubMed ID: 16309422 [TBL] [Abstract][Full Text] [Related]
20. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. Marshall JD; Fearon K; Abbate C; Subramanian S; Yee P; Gregorio J; Coffman RL; Van Nest G J Leukoc Biol; 2003 Jun; 73(6):781-92. PubMed ID: 12773511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]